News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN)'s Not So Secret Weapon



6/18/2014 7:16:01 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

While defending itself from US biotechnology giant, Pfizer, AstraZeneca (LSE: AZN) (NYSE: AZN.US) made an astonishing claim. The company claimed that it has the potential to nearly double its annual sales during the next 10 years. Many City analysts expressed alarm at this forecast, calling it unreasonable. However, the company has a secret weapon — none other than CEO Pascal Soriot, the man who made the forecast in the first place.

Hey, check out all the research scientist jobs. Post your resume today!

Read at News Release


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES